Metformin is the most widely prescribed first-line oral medication for type 2 diabetes worldwide.
Through Vitercure's HIPAA-secure telehealth program, a licensed clinician can evaluate your health
history and, if appropriate, prescribe metformin at the right strength — no lengthy in-person visit required.
Metformin is also commonly used for insulin resistance, prediabetes and polycystic ovary syndrome (PCOS).
All prescriptions require a clinical assessment. Depending on your profile, your prescriber may recommend
metformin alongside — or instead of — GLP-1 medications like
Ozempic®,
Wegovy® or
Mounjaro®.
Evidence-based type 2 diabetes care — online
Answer a short questionnaire. A licensed clinician reviews your history and may prescribe metformin
or another treatment. Discreet, trackable shipping from US and UK pharmacies.
Higher-strength 750mg tablets from licensed US partner pharmacies.
$26.95
One-time medication cost from this source. Telehealth visit may be billed separately.
Metformin 500mg — Source: United Kingdom
500mg metformin tablets from UK-based partner pharmacies.
$28.95
One-time medication cost from this source. Telehealth visit may be billed separately.
Metformin 1000mg — Source: USA
Maximum-strength 1000mg metformin tablets from US partner pharmacies.
$83.95
One-time medication cost from this source. Telehealth visit may be billed separately.
Number of packs
HIPAA-compliant and 256-bit encrypted. Valid prescription required.
Licensed US & UK partner pharmacies
HIPAA-secure telehealth
Discreet, trackable shipping
Vitercure metabolic health library
Patient outcomes on metformin
Individual results vary. These represent reported patient outcomes. Consult your prescriber for personalized expectations.
DK
"After 3 months on metformin, my A1C went from 8.4 to 7.1. My doctor said it was one of the better responses she'd seen. I also lost about 8 lbs without really trying."
A1C: 8.4 → 7.1 · 3 months
PL
"I was diagnosed with PCOS and metformin was the first thing that actually helped regulate my cycle. It's been 6 months and my insulin levels are normal now."
PCOS · 6 months
AS
"Started metformin for prediabetes. Six months later I avoided a diabetes diagnosis entirely. My fasting glucose went from 118 to 94."
Prediabetes · Fasting glucose 118→94
What is Metformin?
Metformin (metformin hydrochloride) is a biguanide medication and the most widely recommended
first-line oral therapy for most adults with type 2 diabetes globally. It has been in clinical
use since 1957 (UK) and 1995 (USA), with an extensive evidence base built over more than six decades.
It works by reducing the amount of glucose your liver releases and improving how your body responds
to insulin — without causing the pancreas to produce more insulin, which means it carries a low
risk of hypoglycemia when used alone.
How metformin works
Liver: Reduces hepatic glucose output — the primary mechanism that lowers fasting blood sugar.
Muscle & fat: Improves insulin sensitivity in peripheral tissues, helping cells take up and use glucose more efficiently.
Gut: Slows intestinal glucose absorption and may influence gut-derived signals that affect appetite and metabolic function.
Low hypoglycemia risk: Does not directly stimulate insulin secretion, so it rarely causes dangerously low blood sugar when taken alone.
Metformin for PCOS
Polycystic ovary syndrome (PCOS) is one of the most common off-label uses of metformin. Because PCOS
is strongly associated with insulin resistance and hyperinsulinemia, metformin can help by improving
insulin sensitivity — which in turn may help regulate menstrual cycles, reduce androgen levels and
improve ovulation in some women. While metformin is not FDA-approved specifically for PCOS, it is
widely used for this purpose per major endocrinology guidelines. Your Vitercure clinician will assess
whether it is appropriate for your situation.
Metformin for prediabetes
The Diabetes Prevention Program (DPP) trial — a landmark US study in 3,234 adults — showed that
metformin reduced the risk of developing type 2 diabetes by 31% over 2.8 years. While lifestyle
intervention (58% risk reduction) outperformed metformin overall, metformin was particularly
effective for younger, heavier individuals and remained beneficial at 15-year follow-up.
Clinicians may prescribe metformin for prediabetes patients who are at high risk and have not
responded adequately to lifestyle changes alone.
Metformin Clinical Evidence — UKPDS & DPP
Metformin's safety and effectiveness are supported by decades of large-scale clinical trials,
including the United Kingdom Prospective Diabetes Study (UKPDS) — one of the longest and most
influential diabetes trials ever conducted.
UKPDS — United Kingdom Prospective Diabetes Study
The UKPDS enrolled 4,075 newly diagnosed patients with type 2 diabetes across 23 UK centres and
followed them for a median of 10 years. In the overweight subgroup treated with metformin:
36% reduction in all diabetes-related endpoints vs conventional therapy
33% reduction in myocardial infarction (heart attack) risk
42% reduction in diabetes-related death
0.9% average A1C reduction from baseline
Source: UK Prospective Diabetes Study Group. Lancet. 1998;352(9131):854-865.
Metformin A1C outcomes by dose
Metformin A1C reduction by dose and patient population
Daily dose
Typical A1C reduction
Notes
500–1000mg/day
0.5–0.8%
Starting/low doses; GI side effects often minimize here.
1500–2000mg/day
0.9–1.5%
Common therapeutic range. Most clinical trial data at this dose.
2500mg/day
Up to 1.8%
Maximum recommended dose. Minimal extra benefit above 2000mg for most.
A1C reductions are approximate and depend on baseline A1C, dose, adherence and lifestyle factors.
Diabetes Prevention Program (DPP) — Prediabetes
In 3,234 US adults with prediabetes followed for 2.8 years, metformin 850mg twice daily reduced
the incidence of type 2 diabetes by 31% compared to placebo. At 15-year follow-up (DPPOS),
metformin continued to show meaningful risk reduction, particularly in those with higher baseline BMI.
Source: Diabetes Prevention Program Research Group. N Engl J Med. 2002;346:393-403.
Metformin and weight loss
Metformin is often described as weight-neutral, but clinical evidence shows a modest weight-loss
effect in many patients — typically 1–3 kg over the first 6–12 months. This is far less than GLP-1
medications like Wegovy® (15.3% body weight)
or Mounjaro® (22.5%), but it is
meaningfully better than most other glucose-lowering medications, which often cause weight gain. For
patients whose primary goal is weight loss, your clinician may recommend a dedicated GLP-1 medication
alongside or instead of metformin.
Metformin Dosing & How to Take It
Standard dose escalation
Timeframe
Typical dose
Purpose
Week 1–2
500mg once daily with dinner
Starter dose; minimizes GI side effects.
Week 3–4
500mg twice daily
With breakfast and dinner if tolerated.
Maintenance
1,000–2,000mg/day
Most clinical data at this range. Split across meals.
Maximum
2,550mg/day
Rarely needed; minimal extra benefit above 2,000mg.
Metformin immediate release vs extended release
Form
How taken
GI tolerance
Available strengths
Immediate release (IR)
2–3× daily with meals
More GI side effects; take with food
500mg, 750mg, 850mg, 1000mg
Extended release (XR/ER)
Once daily with evening meal
Better GI tolerance; fewer stomach effects
500mg, 750mg, 1000mg
Your prescriber will determine the most appropriate form and dose based on your health history and tolerability.
Key administration tips
Always take with food — reduces nausea significantly.
Missed dose — take as soon as remembered with the next meal. Never double dose.
Contrast dye procedures — hold metformin before and after, as directed by your clinician.
Surgery — you may be asked to stop metformin 48 hours before general anesthesia.
Important Safety Information & Warnings
This section does not include all possible safety information. Always review the full Prescribing Information and speak with your healthcare provider before starting or changing any medication.
Do not take metformin if:
You have severe kidney disease or significantly reduced kidney function (eGFR <30).
You have acute or chronic metabolic acidosis, including diabetic ketoacidosis.
You are scheduled for imaging with iodinated contrast dye — hold as directed.
You are allergic to metformin or any of its ingredients.
Lactic acidosis monitoring
Lactic acidosis is rare but serious — especially in people with kidney, liver or heart problems, or during dehydration, infection or heavy alcohol use. Symptoms include unusual fatigue, muscle pain, rapid breathing, stomach pain, feeling cold, dizzy or confused. Seek emergency care immediately if you experience these.
Alcohol and metformin: Alcohol increases the risk of lactic acidosis and hypoglycemia. Avoid heavy drinking. Occasional light use may be acceptable — ask your clinician.
Common side effects
Nausea, diarrhea, stomach upset, gas and a metallic taste are among the most frequently reported, especially when starting or increasing the dose. Taking metformin with food and using gradual dose escalation significantly reduces these effects for most people. Extended-release formulations may be better tolerated if GI symptoms are a concern.
Vitamin B12 monitoring
Long-term metformin use may reduce vitamin B12 absorption in some patients. Your clinician may check B12 levels periodically and recommend supplementation if needed.
Metformin vs GLP-1 & Other Diabetes Medications
Metformin is usually the foundation of type 2 diabetes care. Depending on your A1C, weight goals,
cardiovascular history and insurance, your prescriber may add or switch to other medications.
Comparison of metformin vs GLP-1 medications for diabetes and weight loss
This comparison is educational and does not replace medical advice. Metformin is often prescribed alongside GLP-1 medications, not instead of them.
Can I take metformin with Ozempic, Wegovy or Mounjaro?
Yes. Metformin is commonly prescribed alongside GLP-1 medications. Combining them can provide
complementary mechanisms — metformin addresses hepatic glucose output and insulin sensitivity,
while GLP-1 medications add appetite control, additional A1C reduction and weight loss benefits.
Your Vitercure clinician will determine whether combination therapy is appropriate for your
health profile.
Metformin FAQ
Metformin is primarily FDA-approved for type 2 diabetes, but clinicians commonly prescribe it
for insulin resistance, prediabetes and polycystic ovary syndrome (PCOS). The Diabetes Prevention
Program trial showed a 31% reduction in progression to type 2 diabetes in high-risk individuals.
Vitercure clinicians will assess whether metformin is appropriate for your specific situation.
Metformin is not a dedicated weight-loss drug, but clinical studies consistently show a modest
weight reduction of 1–3 kg (2–7 lbs) in many patients over 6–12 months — making it one of the
few diabetes medications that doesn't cause weight gain. If weight loss is your primary goal,
your prescriber may recommend Wegovy®
(15.3% body weight) or Mounjaro®
(22.5%) instead, possibly alongside metformin.
Metformin extended release (ER or XR) releases the medicine slowly over the course of the day
and is taken once daily, usually with the evening meal. It generally causes fewer gastrointestinal
side effects than the standard immediate-release (IR) form, which is taken 2–3 times per day.
Both forms are equally effective at controlling blood sugar. Your clinician will prescribe
whichever form is most appropriate for your tolerability and lifestyle.
Heavy or binge drinking while taking metformin significantly increases the risk of lactic acidosis
— a rare but serious condition. Alcohol also affects blood sugar in unpredictable ways, which can
interact with diabetes management. Occasional, light alcohol consumption may be acceptable for
some patients, but you should always discuss this with your clinician based on your specific
health profile, kidney function and other medications.
Yes. Metformin has been in clinical use since 1957 and has one of the longest real-world safety
records of any diabetes medication. The UKPDS followed patients for 10 years, and the DPP
Outcomes Study (DPPOS) followed participants for 15+ years — both confirming durable benefits.
Monitoring typically includes periodic kidney function (eGFR) checks and occasional B12 level
checks, as long-term use may reduce B12 absorption in some patients.
Yes — through Vitercure's HIPAA-compliant telehealth program, a licensed clinician can review
your health history and, if appropriate, prescribe metformin without an in-person visit.
Metformin is a prescription-only medication and cannot be legally dispensed without a valid
prescription. A short online questionnaire is all it takes to start the process.
Blood sugar levels will typically begin to rise within days to weeks of stopping metformin,
especially if dietary and lifestyle changes are not maintained. Never stop metformin suddenly
without speaking to your clinician. They can help you taper, switch, or add another medication
if needed.
Yes. Metformin is frequently combined with GLP-1 receptor agonists like
Ozempic®,
Wegovy® and
Mounjaro®.
The combination provides complementary mechanisms — metformin reduces hepatic glucose output
while GLP-1 medications suppress appetite and add A1C and weight benefits. Your Vitercure
clinician will determine whether combination therapy is right for you.
Metformin for Type 2 Diabetes — What the Evidence Shows
Metformin has been the cornerstone of type 2 diabetes care for more than 60 years. The American Diabetes
Association (ADA), the National Institute for Health and Care Excellence (NICE) and the World Health
Organization (WHO) all recommend metformin as the first-line pharmacological treatment for most adults
with type 2 diabetes when lifestyle changes alone are insufficient.
The UKPDS — the most influential diabetes trial of the 20th century — demonstrated that metformin
in overweight patients with type 2 diabetes reduced all-cause diabetes complications by 36%, heart attack
risk by 33% and diabetes-related death by 42%, compared to conventional therapy. These benefits were
independent of blood sugar reduction, suggesting metformin may have direct cardioprotective effects.
Metformin for PCOS — How It Helps
Polycystic ovary syndrome (PCOS) affects up to 10% of women of reproductive age and is strongly
associated with insulin resistance, even in those with a normal body weight. Metformin addresses PCOS
at its metabolic root by reducing insulin levels, which in turn can lower androgen production, improve
ovulation and regulate menstrual cycles.
For women with PCOS who are trying to conceive, metformin may improve ovulation rates. For those
not seeking pregnancy, it can help manage irregular periods and reduce symptoms like excess hair growth
(hirsutism) related to elevated androgens. Combined with lifestyle changes, metformin may also reduce
long-term diabetes risk in women with PCOS, who are at significantly elevated risk.
Metformin is not FDA-approved for PCOS. Its use in this context is off-label and requires evaluation
by a licensed prescriber.
Metformin vs Ozempic — Which Is Right for You?
Metformin and Ozempic® are not
competitors — they work differently and are frequently prescribed together. Metformin is an oral tablet
taken 1–3 times per day that reduces hepatic glucose production and improves insulin sensitivity.
Ozempic is a once-weekly injectable GLP-1 that additionally suppresses appetite, slows digestion and
has demonstrated cardiovascular risk reduction.
For patients whose primary concern is blood sugar control and who prefer oral medication, metformin
is typically the first choice. For patients who also need significant weight loss, cardiovascular
protection or greater A1C reductions, a GLP-1 medication — alone or combined with metformin — may
be more appropriate. Your Vitercure clinician will build the right plan based on your complete
health picture.
Yes — commonly combined for complementary effects.
“
Clinician perspective on metformin
For most adults with type 2 diabetes, metformin is where we start. It is inexpensive, well-understood,
weight-neutral to modestly weight-beneficial, and backed by 60+ years of safety data. It pairs well
with GLP-1 medications when patients need additional blood sugar control, weight loss or cardiovascular
protection. The question is rarely metformin vs GLP-1 — it is usually metformin, and whether to add
a GLP-1 alongside.
This perspective is general and may not apply to your specific situation. A Vitercure clinician will review your labs, medications and history before recommending any treatment.
Medically Reviewed
This page is for educational purposes and does not replace advice from your own healthcare provider.
Dr. Jane Rote, MD
Board-Certified in Endocrinology & Metabolism
Last medical review: November 2025
Content reviewed for clinical accuracy
See if metformin is right for you
Answer a short questionnaire online. A licensed clinician reviews your history and may prescribe
metformin or another treatment that fits your profile. No lengthy in-person visit required.
